Tazidime and Augmentin '125' drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tazidime (ceftazidime) and Augmentin '125' (amoxicillin; clavulanate potassium). Common drug interactions include granuloma among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Tazidime and Augmentin '125'. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.



On Aug, 09, 2026

52 people who take Tazidime and Augmentin '125' together, and have interactions are studied.

Tazidime and Augmentin '125' drug interactions.

What are the common drug interactions of Tazidime and Augmentin '125', by gender? *:

female:

  1. Granuloma (a small area of inflammation due to tissue injury)
  2. Groin pain
  3. Headache (pain in head)
  4. Herpes zoster
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Increased ventricular afterload (increasing left ventricular afterload include elevated blood pressure and aortic valve disease)
  7. Insomnia (sleeplessness)
  8. Joint dislocation (a joint position is changed from normal position)
  9. Joint effusion (presence of extra fluid in joint covering)
  10. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)

male:

  1. Pyrexia (fever)
  2. Sudden death
  3. Aspartate aminotransferase increased
  4. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  5. Diarrhoea
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Liver disorder (liver diseases)
  8. Renal failure (kidney dysfunction)
  9. Acute hepatic failure
  10. Acute tonsillitis

What are the common drug interactions of Tazidime and Augmentin '125', by age (0-1 to 60+)? *:

0-1:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Hepatic failure (liver failure)
  4. Liver disorder (liver diseases)
  5. Acute hepatic failure

2-9:

  1. Acute lymphocytic leukaemia (cancer of the white blood cells)
  2. Adhesion
  3. Conjunctivitis (pink eye)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Overweight
  6. Upper respiratory tract infection
  7. Dental caries
  8. Pyrexia (fever)
  9. Tooth disorder (tooth disease)
  10. Tooth extraction

10-19:

  1. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  2. Factor viii inhibition (suppression of factor viii)
  3. Post procedural complication
  4. Pyrexia (fever)

20-29:

n/a

30-39:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Acute tonsillitis
  3. Diarrhoea
  4. Drug ineffective
  5. Hand and foot syndrome
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Oedema (fluid collection in tissue)
  8. Oedema lower limb (fluid collection in tissue of lower leg)
  9. Pruritus (severe itching of the skin)
  10. Pyrexia (fever)

40-49:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Somnolence (a state of near-sleep, a strong desire for sleep)

50-59:

  1. Neuropathy peripheral (surface nerve damage)

60+:

  1. Pyrexia (fever)
  2. Oedema peripheral (superficial swelling)
  3. Loss of consciousness
  4. Diarrhoea
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  6. Pleural effusion (water on the lungs)
  7. Anaemia (lack of blood)
  8. Dehydration (dryness resulting from the removal of water)
  9. Urinary tract infection
  10. Obstructive airways disorder (a progressive disease that makes it hard to breathe)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 10 people, 19.23%
  2. High Blood Pressure: 7 people, 13.46%
  3. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 6 people, 11.54%
  4. Breast Cancer: 6 people, 11.54%
  5. Stress And Anxiety: 5 people, 9.62%
  6. Reflux Gastritis (a condition in which the lining of a person's stomach becomes inflamed as a result of exposure to bile): 5 people, 9.62%
  7. Pain: 5 people, 9.62%
  8. Febrile Neutropenia (fever with reduced white blood cells): 5 people, 9.62%
  9. Stable Angina (a constant chest pain): 4 people, 7.69%
  10. Diabetic Foot: 4 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and Augmentin '125'?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tazidime and Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tazidime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin '125' and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime and amoxicillin; clavulanate potassium (the active ingredients of Tazidime and Augmentin '125', respectively), and Tazidime and Augmentin '125' (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: